Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
Acuity Brands
AYI
$10.7B
| $1.44M | ﹤0.01% |
7,100
+6,300
| +788% | +$1.11M |
|
2527
AptarGroup
ATR
$8.72B
| $1.44M | ﹤0.01% |
16,596
+14,969
| +920% | +$1.23M |
|
2528
LCI Industries
LCII
$2.59B
| $1.44M | ﹤0.01% |
14,080
-4,941
| -26% | -$474K |
|
2529
Vanguard Morningstar Small-Cap ETF
VB
$82B
| $1.44M | ﹤0.01% |
10,640
| – | – |
|
2530
PUT
Vipshop
VIPS
$7.42B
| $1.44M | ﹤0.01% |
136,600
+84,300
| +161% | +$1.1M |
|
2531
Fomento Económico Mexicano
FMX
$41.6B
| $1.44M | ﹤0.01% |
14,641
+3,742
| +34% | +$349K |
|
2532
CALL
Clorox
CLX
$12.9B
| $1.44M | ﹤0.01% |
10,800
-4,300
| -28% | -$580K |
|
2533
PUT
AutoNation
AN
$6.95B
| $1.44M | ﹤0.01% |
34,100
+25,900
| +316% | +$1.05M |
|
2534
PUT
Westlake Corp
WLK
$9.8B
| $1.44M | ﹤0.01% |
21,700
+19,400
| +843% | +$1.23M |
|
2535
Corcept Therapeutics
CORT
$11.8B
| $1.44M | ﹤0.01% |
121,682
+509
| +0.4% | +$5.53K |
|
|
AMED
2536
DELISTED
Amedisys
AMED
| $1.43M | ﹤0.01% |
22,798
+6,286
| +38% | +$366K |
|
|
BRCD
2537
CALL
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.43M | ﹤0.01% |
113,600
| – | – |
|
|
ARNC.PRB
2538
DELISTED
Arconic Inc.
ARNC.PRB
| $1.43M | ﹤0.01% |
+40,000
| New | +$1.66M |
|
2539
ProShares UltraPro Short QQQ
SQQQ
$1.74B
| $1.43M | ﹤0.01% |
18
+16
| +800% | +$1.32M |
|
2540
CALL
Raymond James Financial
RJF
$34.4B
| $1.43M | ﹤0.01% |
26,700
+9,150
| +52% | +$461K |
|
|
INFN
2541
DELISTED
Infinera Corporation Common Stock
INFN
| $1.43M | ﹤0.01% |
133,939
+79,350
| +145% | +$811K |
|
2542
CALL
AngloGold Ashanti
AU
$48.6B
| $1.42M | ﹤0.01% |
146,300
+104,400
| +249% | +$1.19M |
|
2543
CALL
GoDaddy
GDDY
$11.7B
| $1.42M | ﹤0.01% |
33,500
+33,400
| +33,400% | +$1.34M |
|
2544
CALL
Watsco Inc
WSO
$13.4B
| $1.42M | ﹤0.01% |
9,200
+6,000
| +188% | +$857K |
|
|
EBIX
2545
PUT
DELISTED
Ebix Inc
EBIX
| $1.42M | ﹤0.01% |
26,300
-47,100
| -64% | -$2.71M |
|
2546
Green Dot
GDOT
$760M
| $1.42M | ﹤0.01% |
36,754
+7,937
| +28% | +$287K |
|
|
IPXL
2547
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.42M | ﹤0.01% |
87,980
+86,428
| +5,569% | +$1.28M |
|
2548
CALL
Ball Corp
BALL
$16.7B
| $1.41M | ﹤0.01% |
33,500
+28,100
| +520% | +$1.11M |
|
2549
Hancock Whitney
HWC
$6.25B
| $1.41M | ﹤0.01% |
28,813
+14,848
| +106% | +$699K |
|
2550
CALL
Novartis
NVS
$298B
| $1.41M | ﹤0.01% |
18,860
+14,173
| +302% | +$1M |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.